心構造疾患用デバイスの世界市場 (2018年～2028年)：製品タイプ・処置 (置換術・修復術)・地域別の動向分析・競合市場シェア・予測

世界の心構造疾患用デバイスの市場規模は、2021年の116億3,000万米ドルから、予測期間中は11.1%のCAGRで推移し、2028年末には約241億6,000万米ドルの規模に成長すると予測されています。

同市場は、さまざまな心構造疾患の有病率の上昇、さまざまな経カテーテル心構造疾患製品の適応拡大承認の急増、退行性心臓弁膜症を患う高齢者人口の増加により、活況を呈しています。また、有効性の高い処置に対する需要が増加していること、低侵襲の心構造疾患治療製品が好まれるようになっていること、革新的で技術的に進んだ製品を開発するためのR&D費の増加も同市場の成長の要因となっています。

当レポートでは、世界の心構造疾患用デバイスの市場を調査し、市場概要、市場成長への各種影響因子の分析、法規制環境、技術動向、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、市場シェア、主要企業のプロファイルなどをまとめています。

目次

第1章 調査の枠組み

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の心構造疾患用デバイス市場の洞察

• 産業バリューチェーン分析
• DROC分析
  • 促進要因
  • 抑制要因
  • 機会
  • 課題
• 技術の進歩/最近の開発
• 規制の枠組み
• ポーターのファイブフォース分析

第5章 世界の心構造疾患用デバイス市場の概要

• 市場規模・予測
• 市場シェア・予測
  • 製品タイプ別
    • 心臓弁デバイス
  • 処置別
    • 置換術
    • 修復術
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ

第6章 北米の心構造疾患用デバイス市場

• 市場規模・予測
• 市場シェア・予測
  • 製品タイプ別
  • 処置別
  • 国別

第7章 欧州の心構造疾患用デバイス市場

• 市場規模・予測
• 市場シェア・予測
  • 製品タイプ別
  • 処置別
  • 国別

第8章 アジア太平洋の心構造疾患用デバイス市場

• 市場規模・予測
• 市場シェア・予測
  • 製品タイプ別
  • 処置別
  • 国別

第9章 ラテンアメリカの心構造疾患用デバイス市場

• 市場規模・予測
• 市場シェア・予測
  • 製品タイプ別
  • 処置別
  • 国別

第10章 中東・アフリカの心構造疾患用デバイス市場

• 市場規模・予測
• 市場シェア・予測
  • 製品タイプ別
  • 処置別
  • 国別

第11章 競合情勢

• 主要企業・製品のリスト
• 市場シェア分析
• 競合ベンチマーキング
• 主要な戦略的展開 (M&A・提携)

第12章 サプライヤー分析

第13章 世界の心構造疾患用デバイス産業に対するCOVID-19の影響

第14章 企業プロファイル (会社概要・財務マトリックス・競合情勢・主な人材・主要競合企業・連絡先・戦略的展望)

• Abbott Laboratories
• Affluent Medical SA
• Artivion Inc
• AtriCure Inc
• CORONEO Inc ,
• Braile Biomedica
• Boston Scientific Corporation
• Getinge AB
• Jc Medical Inc
• Johnson and Johnson Inc,
• 他の有力企業

第15章 主要な戦略的推奨事項

Global Structural Heart Devices Market to Grow at a CAGR of 11.1% during Forecast Period

Global Structural Heart Devices Market is flourishing owing to the rising prevalence of various structural heart diseases, a surge in expanded indication approval for various transcatheter structural heart products, and an increase in the geriatric population burdened with various degenerative valvular heart diseases…

A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the Global Structural Heart Devices Market was worth USD 11.63 billion in the year 2021. The market is projected to grow at a CAGR of 11.1%, earning revenues of around USD 24.16 billion by the end of 2028. The Global Structural Heart Devices Market is booming because of the rising structural heart disease cases. Moreover, these diseases are mostly associated with heart valves or tissues. These diseases are known to be congenital, meaning they can be present from birth, though some structural heart diseases develop later in life. Additionally, the increase in demand for highly efficient procedures among people, the growing preference for minimally invasive structural heart therapeutic products among the value-oriented patient population, and the increase in R&D spending for developing innovative and technologically advanced products all contribute to the structural heart devices market's growth. Furthermore, Global Structural Heart Devices Market is one of the most emerging markets that grow continuously owing to the fast integration of new technologies such as the Internet of Things (IoT), Artificial Intelligence (AI), cloud computing, and others. However, Low cardiac surgery affordability and accessibility in developing countries are expected to limit market growth in the coming years. However, a shortage of skilled personnel may have an impact on overall procedural volumes, slowing the rate of market growth during the forecast period (2022-2028).

The Number of Patients Suffering from Structural Heart Disease is Increasing.

Because of the increased number of patients suffering from structural heart diseases, there has been an increase in demand for structural heart devices. Because these disorders are generally congenital, they are very common in newborns. According to The Nemours Foundation, approximately one in every 100 newborns has congenital heart defects, which can range from mild to severe. According to Micro Interventional Devices, Inc., structural heart defects affect approximately 60 million people in the United States, or 20-25 percent of the adult population. According to the Center for Structural Heart Disease at Henry Ford Hospital (CSHD), approximately 250,000 patients are diagnosed with mitral valve diseases each year at Henry Ford Hospital. Furthermore, 1.75 million people in Europe have aortic stenosis. These statistics demonstrate the need for structural heart treatment devices, providing impetus to develop new techniques for heart defect repair and replacement. TAVR procedures were approved in Europe in 2007, and in the United States in 2012. Furthermore, each year, approximately 80,000 patients undergo mitral valve repair or valve replacement surgery. All these factors boost the growth of the Global Structural Heart Devices Market during the forecast period (2022-2028).

Demand for minimally invasive procedures is increasing

Because structural cardiac procedures and devices are less intrusive than other procedures, such as open-heart operations, they are highly desired. Professionals in cardiology routinely perform minimally invasive procedures to replace the aortic, mitral, and artificial heart valves to treat disorders with the structural heart. Additionally, innovative advancements in the structural heart treatment and device markets, such as left arterial appendage closure devices, aortic valve replacement valves, and the introduction of biological and tissue valves, are anticipated to offer potential prospects in the projected future.

Challenge: The Structural Heart Device Approval Process is Rigorous.

Most countries have stringent approval processes for structural heart devices because these are highly specialized devices that are implanted in the body. According to the FDA, structural heart devices are class III devices, whereas these devices are CE mark classified as class IIa (heart valve occluders and testers) and class III (for prosthetic and biological heart valves). Furthermore, the procedure is time-consuming and expensive. According to the Advanced Medical Technology Association, FDA-linked approval stages account for approximately 77 percent and 80 percent of the total cost of commercializing a class II and class III medical device in the market, respectively.

Segmental Coverage

The Global Structural Heart Devices Market is divided into Replacement procedures are further subdivided into TAVR (transcatheter aortic valve replacement) procedures and SAVR (surgical aortic valve replacement) procedures, while repair procedures are further subdivided into Closure Procedures, Annuloplasty, Valvuloplasty, TMVR Procedures, and Others. During the forecast period, the replacement procedures segment will have the largest market share (2022-2028). The segment's growth can be attributed to the long-term durability of these procedures, as well as the widespread preference for transcatheter replacement. During the forecast period, all of these factors contribute to the growth of the Global Structural Heart Devices Market (2022-2028).

Impact of COVID-19 on Global Structural Heart Devices Market

Around the world, the COVID-19 pandemic has affected several different businesses. Governments all across the world enacted stringent lockdown regulations and social segregation standards to slow the pandemic's quick spread. Manufacturing plants all across the world were closed during the pandemic's early phases. The commercialization of the structural heart devices market may also be significantly delayed as a result of the economic crisis that followed the pandemic. Supply chain interruptions presented several difficulties for market participants. However, things will get better over the projection period (2022-2028) as more supplies become available in the second half of 2022.

Competitive Landscape

The leading market players in the Global Structural Heart Devices Market are Abbott Laboratories, Affluent Medical SA, Artivion Inc, AtriCure Inc, CORONEO Inc, Braile Biomedica, Boston Scientific Corporation, Getinge AB, Jc Medical Inc, Johnson and Johnson Inc, and other prominent players

The Global Structural Heart Devices Market is highly fragmented with the presence of several manufacturing companies in the country. The market leaders retain their supremacy by spending on research and development, incorporating cutting-edge technology into their goods, and releasing upgraded items for customers. Various tactics, including strategic alliances, agreements, mergers, and partnerships, are used.

Don't miss the business opportunity in the Global Structural Heart Devices Market. Consult our analysts to gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the Global Structural Heart Devices Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Structural Heart Devices Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

About Us

BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing both qualitative and quantitative data to boost the performance of your business solutions. BWC has built its reputation from the scratch by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.

Table of Contents

1. Research Framework

• 1.1. Research Objective
• 1.2. Product Overview
• 1.3. Market Segmentation

2. Research Methodology

• 2.1. Qualitative Research
  • 2.1.1. Primary & Secondary Research
• 2.2. Quantitative Research
• 2.3. Market Breakdown & Data Triangulation
  • 2.3.1. Secondary Research
  • 2.3.2. Primary Research
• 2.4. Breakdown of Primary Research Respondents, By Region
• 2.5. Assumption & Limitation

3. Executive Summary

4. Global Structural Heart Devices Market Insights

• 4.1. Industry Value Chain Analysis
• 4.2. DROC Analysis
  • 4.2.1. Growth Drivers
  • 4.2.2. Restraints
  • 4.2.3. Opportunities
  • 4.2.4. Challenges
• 4.3. Technological Advancement/Recent Development
• 4.4. Regulatory Framework
• 4.5. Porter's Five Forces Analysis
  • 4.5.1. Bargaining Power of Suppliers
  • 4.5.2. Bargaining Power of Buyers
  • 4.5.3. Threat of New Entrants
  • 4.5.4. Threat of Substitutes
  • 4.5.5. Intensity of Rivalry

5. Global Structural Heart Devices Market Overview

• 5.1. Market Size & Forecast by Value, 2018-2028
  • 5.1.1. By Value (USD Million)
• 5.2. Market Share & Forecast
  • 5.2.1. By Product type
    • 5.2.1.1. Heart Valve Devices
    • 5.2.1.1.1. Transcatheter Heart Valves
    • 5.2.1.1.2. Surgical Heart Valve
    • 5.2.1.1.2.1. Tissue Heart Valves
    • 5.2.1.1.2.2. Mechanical Heart Valve
    • 5.2.1.1.3. Occuluders & Delivery Systems
    • 5.2.1.1.4. Annuloplasty Rings
    • 5.2.1.1.5. Accessories
    • 5.2.1.1.6. Others
  • 5.2.2. By Procedure
    • 5.2.2.1. Replacement Procedures
    • 5.2.2.1.1. TAVR Procedures
    • 5.2.2.1.2. SAVR Procedures
    • 5.2.2.2. Repair Procedures
    • 5.2.2.2.1. Closure Procedures
    • 5.2.2.2.2. Annuloplasty
    • 5.2.2.2.3. Valvuloplasty
    • 5.2.2.2.4. TMVR Procedures
    • 5.2.2.2.5. Others
  • 5.2.3. By Region
    • 5.2.3.1. North America
    • 5.2.3.2. Europe
    • 5.2.3.3. The Asia Pacific
    • 5.2.3.4. Latin America
    • 5.2.3.5. The Middle East and Africa

6. North America Structural Heart Devices Market

• 6.1. Market Size & Forecast by Value, 2018-2028
  • 6.1.1. By Value (USD Million)
• 6.2. Market Share & Forecast
  • 6.2.1. By Product type
  • 6.2.2. By Procedure
  • 6.2.3. By Country
    • 6.2.3.1. United States
    • 6.2.3.2. Canada

7. Europe Structural Heart Devices Market

• 7.1. Market Size & Forecast by Value, 2018-2028
  • 7.1.1. By Value (USD Million)
• 7.2. Market Share & Forecast
  • 7.2.1. By Product type
  • 7.2.2. By Procedure
  • 7.2.3. By Country
    • 7.2.3.1. Germany
    • 7.2.3.2. United Kingdom
    • 7.2.3.3. Italy
    • 7.2.3.4. France
    • 7.2.3.5. Spain
    • 7.2.3.6. Rest of Europe

8. The Asia Pacific Structural Heart Devices Market

• 8.1. Market Size & Forecast by Value, 2018-2028
  • 8.1.1. By Value (USD Million)
• 8.2. Market Share & Forecast
  • 8.2.1. By Product type
  • 8.2.2. By Procedure
  • 8.2.3. By Country
    • 8.2.3.1. China
    • 8.2.3.2. India
    • 8.2.3.3. Japan
    • 8.2.3.4. South Korea
    • 8.2.3.5. Rest of Asia Pacific

9. Latin America Structural Heart Devices Market

• 9.1. Market Size & Forecast by Value, 2018-2028
  • 9.1.1. By Value (USD Million)
• 9.2. Market Share & Forecast
  • 9.2.1. By Product type
  • 9.2.2. By Procedure
  • 9.2.3. By Country
    • 9.2.3.1. Brazil
    • 9.2.3.2. Mexico
    • 9.2.3.3. Rest of Latin America

10. The Middle East & Africa Structural Heart Devices Market

• 10.1. Market Size & Forecast by Value, 2018-2028
  • 10.1.1. By Value (USD Million)
• 10.2. Market Share & Forecast
  • 10.2.1. By Product type
  • 10.2.2. By Procedure
  • 10.2.3. By Country
    • 10.2.3.1. Saudi Arabia
    • 10.2.3.2. UAE
    • 10.2.3.3. South Africa
    • 10.2.3.4. Rest of Middle East & Africa

11. Competitive Landscape

• 11.1. List of Key Players and Their Offerings
• 11.2. Market Share Analysis, 2021
• 11.3. Competitive Benchmarking, By Operating Parameters
• 11.4. Key Strategic Development (Merger, Acquisition, Partnership.)

12. Supplier Analysis

13. Impact of Covid-19 on Global Structural Heart Devices Market Industry

14. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **

• 14.1. Abbott Laboratories
• 14.2. Affluent Medical SA
• 14.3. Artivion Inc
• 14.4. AtriCure Inc
• 14.5. CORONEO Inc ,
• 14.6. Braile Biomedica
• 14.7. Boston Scientific Corporation
• 14.8. Getinge AB
• 14.9. Jc Medical Inc
• 14.10. Johnson and Johnson Inc,
• 14.11. Other Prominent Players

15. Key Strategic Recommendations

*Financial information in case of non-listed companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable

List Of Figures

• Figure 1: Global Structural Heart Devices Market Segmentation
• Figure 2: Global Structural Heart Devices Industry Value Chain Analysis
• Figure 3: Global Structural Heart Devices Market Size, By Value (USD Million),2018-2028
• Figure 4: Global Structural Heart Devices Market Share (%), By Product type, By Value, 2018-2028
• Figure 5: Global Structural Heart Devices Market Share (%), By Procedure, By Value, 2018-2028
• Figure 6: Global Structural Heart Devices Market Share (%), By Country, By Value, 2018-2028
• Figure 7: North America Structural Heart Devices Market Size, By Value (USD Million), 2018-2028
• Figure 8: North America Structural Heart Devices Market Share (%), By Product type, By Value, 2018-2028
• Figure 9: North America Structural Heart Devices Market Share (%), By Procedure, By Value, 2018-2028
• Figure 10: North America Structural Heart Devices Market Share (%), By Country, By Value, 2018-2028
• Figure 11: Europe Structural Heart Devices Market Size, By Value (USD Million), 2018-2028
• Figure 12: Europe Structural Heart Devices Market Share (%), By Product type, By Value, 2018-2028
• Figure 13: Europe Structural Heart Devices Market Share (%), By Procedure, By Value, 2018-2028
• Figure 14: Europe Structural Heart Devices Market Share (%), By Country, By Value, 2018-2028
• Figure 15: The Asia-Pacific Structural Heart Devices Market Size, By Value (USD Million), 2018-2028
• Figure 16: The Asia-Pacific Structural Heart Devices Market Share (%), By Product type, By Value, 2018-2028
• Figure 17: The Asia-Pacific Structural Heart Devices Market Share (%), By Procedure, By Value, 2018-2028
• Figure 18: The Asia-Pacific Structural Heart Devices Market Share (%), By Country, By Value, 2018-2028
• Figure 19: Latin America Structural Heart Devices Market Size, By Value (USD Million), 2018-2028
• Figure 20: Latin America Structural Heart Devices Market Share (%), By Product type, By Value, 2018-2028
• Figure 21: Latin America Structural Heart Devices Market Share (%), By Procedure, By Value, 2018-2028
• Figure 22: Latin America Structural Heart Devices Market Share (%), By Country, By Value, 2018-2028
• Figure 23: The Middle East & Africa Structural Heart Devices Market Size, By Value (USD Million),2018-2028
• Figure 24: The Middle East & Africa Structural Heart Devices Market Share (%), By Product type, By Value, 2018-2028
• Figure 25: The Middle East & Africa Structural Heart Devices Market Share (%), By Procedure, By Value, 2018-2028
• Figure 26: The Middle East & Africa Structural Heart Devices Market Share (%), By Country, By Value, 2018-2028
• Figure 27: Global Structural Heart Devices Market Share Analysis, 2021

List Of Tables

• Table 1: Global Structural Heart Devices Market Size, By Product type, By Value (USD Million), 2018-2028
• Table 2: Global Structural Heart Devices Market Size, By Procedure, By Value (USD Million), 2018-2028
• Table 3: Global Structural Heart Devices Market Size. By Country, By Value (USD Million), 2018-2028
• Table 4: North America Structural Heart Devices Market Size, By Product type, By Value (USD Million), 2018-2028
• Table 5: North America Structural Heart Devices Market Size, By Procedure, By Value (USD Million), 2018-2028
• Table 6: North America Structural Heart Devices Market Size (USD Million), By Country, By Value 2018-2028
• Table 7: Europe Structural Heart Devices Market Size, By Product type, By Value (USD Million), By Value 2018-2028
• Table 8: Europe Structural Heart Devices Market Size, By Procedure, By Value (USD Million), By Value 2018-2028
• Table 9: 40 Europe Structural Heart Devices Market Size (USD Million), By Country, By Value 2018-2028
• Table 10: The Asia-Pacific Structural Heart Devices Market Size, By Product type, By Value (USD Million), By Value 2018-2028
• Table 11: The Asia-Pacific Structural Heart Devices Market Size (USD Million), By Product type, By Value 2018-2028
• Table 12: The Asia-Pacific Structural Heart Devices Market Size (USD Million), By Procedure, By Value 2018-2028
• Table 13: The Asia-Pacific Structural Heart Devices Market Size (USD Million), By Country, By Value 2018-2028
• Table 14: Latin America Structural Heart Devices Market Size, By Product type, By Value (USD Million), By Value 2018-2028
• Table 15: Latin America Structural Heart Devices Market Size, By Procedure, By Value (USD Million), 2018-2028
• Table 16: Latin America Structural Heart Devices Market Size (USD Million), By Country, By Value 2018-2028
• Table 17: The Middle East & Africa Structural Heart Devices Market Size, By Product type, By Value (USD Million), 2018-2028
• Table 18: The Middle East & Africa Structural Heart Devices Market Size, By Procedure, By Value (USD Million), 2018-2028
• Table 19: The Middle East & Africa Structural Heart Devices Market Size (USD Million), By Country, By Value 2018-2028
• Table 20: List of Key Players and Their Offerings
• Table 21: Competitive Benchmarking, by Operating Parameters
• Table 22 Abbott Laboratories Company Overview
• Table 23 Abbott Laboratories Financial Overview
• Table 24 Affluent Medical SA Company Overview
• Table 25 Affluent Medical SA Financial Overview
• Table 26 Artivion Inc Company Overview
• Table 27 Artivion Inc Financial Overview
• Table 28 AtriCure Inc Company Overview
• Table 29 AtriCure Inc Financial Overview
• Table 30 CORONEO Inc Company Overview
• Table 31 CORONEO Inc Financial Overview
• Table 32 Braile Biomedica Company Overview
• Table 33 Braile Biomedica Financial Overview
• Table 34 Boston Scientific Corporation Company Overview
• Table 35 Boston Scientific Corporation Financial Overview
• Table 36 Getinge AB Company Overview
• Table 37 Getinge AB Financial Overview
• Table 38 Jc Medical Inc Company Overview
• Table 39 Jc Medical Inc Financial Overview
• Table 40 Johnson and Johnson Inc Company Overview
• Table 41 Johnson and Johnson Inc Financial Overview